WO2014138723A3 - Physical optimization beverage - Google Patents

Physical optimization beverage Download PDF

Info

Publication number
WO2014138723A3
WO2014138723A3 PCT/US2014/022204 US2014022204W WO2014138723A3 WO 2014138723 A3 WO2014138723 A3 WO 2014138723A3 US 2014022204 W US2014022204 W US 2014022204W WO 2014138723 A3 WO2014138723 A3 WO 2014138723A3
Authority
WO
WIPO (PCT)
Prior art keywords
exercise
methods
increasing
illness
provides novel
Prior art date
Application number
PCT/US2014/022204
Other languages
French (fr)
Other versions
WO2014138723A2 (en
Inventor
Suzannah Jane ROBERTS
Stephanie Jo BLACKWELL
Shannon Joe BROWN
Original Assignee
Cognate3 Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognate3 Llc filed Critical Cognate3 Llc
Publication of WO2014138723A2 publication Critical patent/WO2014138723A2/en
Publication of WO2014138723A3 publication Critical patent/WO2014138723A3/en
Priority to US16/881,880 priority Critical patent/US20200281968A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides novel methods of making a non-corrosive base solution for use as an alkalinity increasing agent and/or antioxidant. The compositions and methods described herein are useful for optimizing health and performance: preventing illness; decreasing recovery times from exertion, illness, and injury; increasing energy levels; improving exercise performance; improving hydration: preventing muscle damage after exercise; and increasing stamina during exercise. The present invention further provides novel compositions and methods which can be used to provide relief from disorders related to or complicated by acidosis or excessive free radical or other reactive oxygen species production.
PCT/US2014/022204 2013-03-08 2014-03-09 Physical optimization beverage WO2014138723A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/881,880 US20200281968A1 (en) 2013-03-08 2020-05-22 Physical optimization beverage

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361774622P 2013-03-08 2013-03-08
US201361774626P 2013-03-08 2013-03-08
US61/774,622 2013-03-08
US61/774,626 2013-03-08

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/201,865 Continuation US20140255371A1 (en) 2013-03-08 2014-03-09 Physical Optimization Beverage

Publications (2)

Publication Number Publication Date
WO2014138723A2 WO2014138723A2 (en) 2014-09-12
WO2014138723A3 true WO2014138723A3 (en) 2014-11-06

Family

ID=51492038

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2014/022203 WO2014138722A1 (en) 2013-03-08 2014-03-09 Process for the preparation of a non-corrosive base solution and methods of using same
PCT/US2014/022204 WO2014138723A2 (en) 2013-03-08 2014-03-09 Physical optimization beverage

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2014/022203 WO2014138722A1 (en) 2013-03-08 2014-03-09 Process for the preparation of a non-corrosive base solution and methods of using same

Country Status (1)

Country Link
WO (2) WO2014138722A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108408866A (en) * 2017-02-09 2018-08-17 朱洪立 Three clear anion waters

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000791A1 (en) * 1978-10-13 1980-05-01 Schwimmer A B-glucuronidase activity and/or ph-dependent pharmaceuticals and their methods of production and use for selective treatment of diseases
US4830862A (en) * 1987-07-31 1989-05-16 The Procter & Gamble Company Calcium-supplemented beverages and beverage concentrates containing low levels of sulfate
US20090047267A1 (en) * 2007-07-02 2009-02-19 Stephen Ray Wurzburger Process for the Preparation of A Non-Corrosive Base Solution And Methods Of Using Same
US20100043783A1 (en) * 2007-01-24 2010-02-25 Suedzucker Aktiengesellschaft Mannheim/Ochsenfurt Raw juice alkalinization
US20110186496A1 (en) * 2008-09-30 2011-08-04 Paul Michael Pedersen Appliances for the alkalizing of water
US20120039951A1 (en) * 2010-05-07 2012-02-16 Revalesio Corporation Compositions and methods for enhancing physiological performance and recovery time

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005074724A1 (en) * 2004-02-04 2005-08-18 Kim, Won-Jik Calcium ion drink that intake uses possible hi-condensed calcium aqueous solution manugaxture method and this
GB0619786D0 (en) * 2006-10-06 2006-11-15 Inst Of Technology Sligo An antimicrobial and immunostimulatory system
ATE548332T1 (en) * 2007-09-13 2012-03-15 Rheinkalk Gmbh METHOD FOR INCREASING THE PH OF ACIDIC WATERS
DE102007049612A1 (en) * 2007-10-17 2009-06-10 Evonik Goldschmidt Gmbh Bioactive composition for cosmetic applications
EP2219600A4 (en) * 2007-11-19 2012-09-12 Stiefel Laboratories Topical cosmetic skin lightening compositions and methods of use thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1980000791A1 (en) * 1978-10-13 1980-05-01 Schwimmer A B-glucuronidase activity and/or ph-dependent pharmaceuticals and their methods of production and use for selective treatment of diseases
US4830862A (en) * 1987-07-31 1989-05-16 The Procter & Gamble Company Calcium-supplemented beverages and beverage concentrates containing low levels of sulfate
US20100043783A1 (en) * 2007-01-24 2010-02-25 Suedzucker Aktiengesellschaft Mannheim/Ochsenfurt Raw juice alkalinization
US20090047267A1 (en) * 2007-07-02 2009-02-19 Stephen Ray Wurzburger Process for the Preparation of A Non-Corrosive Base Solution And Methods Of Using Same
US20110186496A1 (en) * 2008-09-30 2011-08-04 Paul Michael Pedersen Appliances for the alkalizing of water
US20120039951A1 (en) * 2010-05-07 2012-02-16 Revalesio Corporation Compositions and methods for enhancing physiological performance and recovery time

Also Published As

Publication number Publication date
WO2014138723A2 (en) 2014-09-12
WO2014138722A1 (en) 2014-09-12

Similar Documents

Publication Publication Date Title
EP3426061A4 (en) Methods and compositions to improve weight loss and cardiometabolic health beyond diet and exercise
MX2018003235A (en) Flavonoid compositions and methods of use.
WO2017100726A8 (en) Methods for treating huntington's disease
PH12015501494A1 (en) Method for producing substituted 5-fluoro-1h-pyrazolopyrimidines
TN2017000009A1 (en) Spirocycloheptanes as inhibitors of rock.
PH12014502624A1 (en) Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
MX342409B (en) Treatment of cardiac conditions.
IN2015DN02573A (en)
MX2013005429A (en) Performance enhancing sports beverage and methods of use.
MY188227A (en) Settable compositions comprising wollastonite and pumice and methods of use
MY172673A (en) Non-alcohol, beer-taste beverage having substantiality in taste
MX2016005760A (en) Gsk-3 inhibitors.
MX362418B (en) Tablet binding compositions.
WO2013093096A8 (en) Ellagitannins rich extracts composition in sexual wellness
TN2016000435A1 (en) Novel macrocyclic compounds.
MX2018015385A (en) Soft chewable composition comprising psyllium.
EA201171466A1 (en) COMPOSITION OF UNTESERTAINABLE SALT, METHOD OF ITS RECEPTION AND USE
WO2012097272A8 (en) Stable hydrogel compositions including additives
MX2016004963A (en) Salt and crystal forms of plk-4 inhibitor.
MX2018002851A (en) Composition for topical application comprising dimethyl isosorbide, a polyol, and a phenolic or polyphenolic antioxidant.
WO2014068033A3 (en) Animal model for type 2 diabetes and obesity
MY169325A (en) A composition for preparation of viscoelastic crosslinked hyaluronic acid, and crosslinked hyaluronic acid obtained by using the same
EP2596787A4 (en) New use of hesperetin
WO2014138723A3 (en) Physical optimization beverage
WO2011145909A3 (en) Novel use of panduratin derivatives or an extract of boesenbergia pandurata for promoting muscle mass growth, fighting fatigue, and enhancing exercise performance capability

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14759835

Country of ref document: EP

Kind code of ref document: A2

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 21-12-2015)

122 Ep: pct application non-entry in european phase

Ref document number: 14759835

Country of ref document: EP

Kind code of ref document: A2